Epithelial cell expansion drives cyst progression in genetic models of autosomal recessive polycystic kidney disease
- iScience. 2026 Jun 5;29(6):116288. doi: 10.1016/j.isci.2026.116288.
- 1. Institute of Developmental Biology and Regenerative Medicine, Southwest University, Beibei, Chongqing 400715, China.
- 2. School of Fine Arts, Southwest University, Beibei, Chongqing 400715, China.
- 3. National Health Commission Key Laboratory of Birth Defects for Research and Prevention, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan 410028, China.
- 4. Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410000, China.
- 5. The Affiliated Hospital of Wuhan Sports University, Wuhan, Hubei 430079, China.
- 6. Research Center of Stem Cells and Ageing, Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, Chongqing 400722, China.
- 7. School of Life Sciences, Fudan University, Shanghai 200433, China.
- 8. Key Laboratory of Reproductive Health Diseases Research and Translation of Ministry of Education & Key Laboratory of Human Reproductive Medicine and Genetic Research of Hainan Province & Hainan Provincial Clinical Research Center for Thalassemia, The First Affiliated Hospital of Hainan Medical University, Hainan Medical University, Haikou, Hainan 571101, China.
Autosomal recessive polycystic kidney disease (ARPKD) is a pediatric genetic nephropathy caused by mutations in PKHD1, which encodes fibrocystin. The cellular basis and epithelial dynamics of cyst formation remain incompletely understood. We used lineage-tracing systems in rat and mouse to define epithelial behavior during cystogenesis. Clonal labeling revealed that renal and biliary epithelial cells undergo marked expansion as cysts form. Genetic mosaic analysis showed that individual Pkhd1-deficient cholangiocytes can generate millimeter-scale cysts within one year. Mathematical modeling demonstrated that biliary epithelial proliferation alone can account for cyst growth to millimeter size within weeks to months, depending on initial cell number and doubling time. Transcriptomic profiling of early cystic liver identified upregulated cell-cycle regulators, including CDK1. Pharmacological CDK1 inhibition attenuated fibrocystic liver disease in vivo. These findings show that epithelial cell expansion is the primary driver of cystogenesis and loss of fibrocystin activates a pro-proliferative program that can be therapeutically targeted.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Estrogen Receptor/ERRResearch Areas: Cancer